Halal Nutraceuticals & Vaccines Market to reach US$ 131253.4 Million by 2032 | FMI

 The global Halal Nutraceuticals & Vaccines Market size is expected to grow at a phenomenal CAGR of 7.7% over the projection period from 2022 to 2032. The global market is expected to be valued at US$ 62,510.5 Million in 2022 and total around US$ 131,253.4 Million by 2032.

According to the Future Market Insights historical analysis, the sales of the global halal nutraceuticals & vaccines market were registered at a total CAGR of 6.5% from 2016 to 2021. The growth in the market is on the rise due to the demand for halal products in the vast Muslim population countries, which is bolstering the market growth.   

.To learn more about this report: https://www.futuremarketinsights.com/reports/halal-nutraceuticals-and-vaccines-market

Halal nutraceuticals & vaccines are known as a crucial domestic commodity that has permeated into almost every section of society, leading to a robust and growing global Halal Nutraceuticals & Vaccines market. Manufacturers are rapidly tapping into several other markets due to the increasing Muslim population in countries such as Indonesia, Malaysia, Singapore, and other countries of Asia Pacific excluding Japan (APEJ).  

Surging demand for halal-certified products across APEJ is anticipated to bolster the market demand with an impressive market index of more than 6.2 during the forecast period. More than 80% of the global halal nutraceuticals & vaccines market revenue is anticipated to be accounted for by Middle East & Africa (MEA) and APEJ collectively. Favorable government initiatives and campaigns that have been undertaken for encouraging halal products are also predicted to benefit the global market. Growth prospects are likely to remain positive over the coming years, supported by increasing demand for halal dietary supplements. Hospital pharmacies and retail pharmacies will exhibit high demand. The

Key Takeaways

  • Government initiatives all over the world are expected to act favorably for the global Halal Supplements & Preventive Medicines market as it promotes the consumption of halal products resulting in higher demands. Furthermore, increasing demand from the Muslim population will spur the demand for halal dietary supplements.
  • According to the world and population trends, it has been predicted that by 2023, the world’s Muslim population will reach over 2.2 billion people across the globe. With growing awareness about the halal ingredients combined with the prevalence of lifestyle disorders, people are opting for halal dietary supplements such as general well-being, weight loss, and others.
  • Surging initiatives from governments of countries with vast Muslim populations are significantly encouraging investments in the production of halal products will improve growth. Furthermore, the adoption of uniform certification for halal products & increasing funds across Malaysia, India, Singapore, and other Asia Pacific excluding Japan (APEJ) countries will accelerate the growth over the forecast period.
  • The Malaysian government which falls under the association of the Ministry of International Trade & Industry developed halal products & services to promote halal products and make the country a halal hub. These initiatives are anticipated to boost market growth and provide lucrative revenue for the market players, specifically across APEJ and MEA.

Competitive Landscape

  • Abbott Laboratories,
  • Nestlé
  • Amway
  • Herbalife International of America, Inc.
  • AJ Biologics Sdn Bhd.
  • Agropur, Inc.

Key Segments Covered In The Halal Nutraceuticals & Vaccines Industry Analysis

By Product Type:

  • Halal Dietary Supplements
  • Halal Vaccines

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales
  • Super Markets

By Application:

  • Sports Nutrition
  • General Wellbeing
  • Immune & Digestive Health
  • Bone & Joint Health
  • Heart Health
  • Disease Prevention
  • Weight Loss

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Primary Sclerosing Cholangitis (PSC) Market Size, Opportunities and Forecast 2023-2033

Image
  The global Primary Sclerosing Cholangitis (PSC) Market is anticipated to be worth US$ 151.07 million in 2023.  Primary Sclerosing Cholangitis (PSC) With growing alcohol consumption, the worldwide market for Primary Sclerosing Cholangitis (PSC) is expected to develop at a CAGR of 7.6% between 2023 and 2033, totaling roughly US$ 314.26 Million by 2033. According to the analysis of Future Market Insights, the Primary Sclerosing Cholangitis (PSC) market is expected to fuel over the analysis period, attributed to the factors such as the rise in the incidences of liver diseases, as well as rise in alcohol consumption. Get Full Access @ https://www.futuremarketinsights.com/reports/primary-sclerosing-cholangitis-psc-market  As per the Centers for Disease Control and Prevention, the global incidence of liver disease was 3.9 million in 2016. As per the World Health Organization (WHO), prevalence of liver cirrhosis is increasing in the European countries, due to high con...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more